Alain Kentos

Jolimont, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.

Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.

Journal: The New England journal of medicine

Published: December 09, 2025

BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study.

BCMA-targeting BiTE molecule AMG 420 in relapsed or refractory multiple myeloma: a phase 1b open-label expansion study.

Journal: Leukemia & lymphoma

Published: July 21, 2025

Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.

Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.

Journal: Blood advances

Published: June 09, 2025

Prospective comparison between geriatric assessment and clinical evaluation in 200 newly diagnosed older adults with multiple myeloma.

Prospective comparison between geriatric assessment and clinical evaluation in 200 newly diagnosed older adults with multiple myeloma.

Journal: Journal of geriatric oncology

Published: November 25, 2024

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.

Journal: Blood

Published: June 25, 2024

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 04, 2021

Recommendations on the management of multiple myeloma in 2020.

Recommendations on the management of multiple myeloma in 2020.

Journal: Acta clinica Belgica

Published: December 23, 2020

COVID-19, impact on myeloma patients.

COVID-19, impact on myeloma patients.

Journal: Annals of hematology

Published: May 08, 2020

Reply to M. Lambertini et al.

Reply to M. Lambertini et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 29, 2016

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 25, 2016

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia.

Journal: Blood

Published: December 26, 2014

Myelofibrosis patients in Belgium: disease characteristics.

Myelofibrosis patients in Belgium: disease characteristics.

Journal: Acta clinica Belgica

Published: November 08, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026